The urological complications associated with 128 consecutive renal transplants performed in the Department of Urclogy of the University Hospital Heidelberg between February 1967 and January 1975 arc described. Extravesical ureteroneocystostomy has shown to be the preferable method for urinary tract reconstruction,providing satisfactory results in our hands. The technique of ureteroneocystostomy at the dome of the bladder, performed since 1967 in our series, is described and its advantages discussed. There was an overall incidence of urological complications of 21.2 %. Major urological complications occurred in 18 patients (14.1 %),urinary fistulae in 11 patients (8.6 %), ureteric obstruction in 4 patients (3.2 %) and spontaneous parenchymal ruptures in 3 patients(2. 3 %). Only two grafts were lost, due to spontaneous parcnchymal rupturcs. The mortality directly due to major urological complications was 5.6 %. Minor complications (hydrocele, epid idymitis,urethral stricturc, urinary calculi) were seen in 9 patients(7 %). Lymphocelcs were not encountered. The management and outcome of urological complications are describcd.

Keywords:
Renal transplantation, Urological complications, Urcteral reimplantation, Kidney
This content is only available via PDF.
1975
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.